BATS BZX Real-Time Price
As of 12:23pm ET
| +6.76 / +3.94%|
The 18 analysts offering 12-month price forecasts for Amgen have a median target of 183.00, with a high estimate of 202.00 and a low estimate of 139.00. The median estimate represents a +2.55% increase from the last price of 178.45.
The current consensus among 22 polled investment analysts is to Hold stock in Amgen. This rating has held steady since July, when it was downgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.